Who are we?
Our role
Is to make it easier for you to access pharmaceutical markets.
We are your partner for drug price strategy and access to drug market. We will help you achive the excellence that healthcare players demand.
Areas of activity:
·preparation of Budget Impact Study
·preparation of Expert Opinion
·pricing strategy and implementation
·adaptation of cost-effectiveness models
·responsible person for good distribution practice – medicines and medical devices
Our core value:
Twenty years of experience in Market Access, Pricing and Health Economics.
Founder and owner - siniša antolić
The pharmacist with professional experience in market access, pharmacoeconomics and pricing.
Demonstrated efficient history of market access, pharmacoeconomic and pricing for almost twenty years working for Roche.
Education
·Farmaceutsko-biokemijski fakultet: mag. pharm.
·Prirodoslovno matematički fakultet: mr. sc.
·Ekonomski fakultet: mr. sc.
·WU (Vienna University of Economics and Business): Mr. sc.
·The London School of Economics and Political Science (LSE)
·University of York
·University of Oxford, Health Economics Research Centre, Nuffield Department of Population Health
·UMIT, Institute of Public Health, Medical Decision Making and Health Technology Assessment
Author of profession publications
·Value in Health – regional edition; Pricing, market access
·JHPOR – J. of Health Policy & Outcomes Research; Public health emergencies
